Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy

Epidemiology and Infection

Volumn 139, Issue 1, 2011, Pages 68-79

  Ajelli, M ^a   Merler, S ^a   Pugliese, A ^b   Rizzo, C ^c  

^a FONDAZIONE BRUNO KESSLER   (Italy)

^b UNIVERSITY OF TRENTO   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Influenza; mathematical modelling; public health

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

ARTICLE; DISEASE SURVEILLANCE; FLU LIKE SYNDROME; HEALTH CARE PLANNING; HEALTH CARE POLICY; INFECTION CONTROL; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INFORMATION PROCESSING; ITALY; MATHEMATICAL MODEL; PANDEMIC INFLUENZA; PREDICTION; PROCESS MODEL; PUBLIC HEALTH SERVICE; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGY; INFLUENZA; PANDEMIC;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; ITALY; MODELS, BIOLOGICAL; PANDEMICS;

EID: 79951545834     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810001317     Document Type: Article

References (36)

1. Merler S, Ajelli M. The role of population heterogeneity and human mobility in the spread of pandemic influenza. Proceedings of the Royal Society B: Biological Sciences 2010; 277: 557-565.
2. Merler S, Ajelli M, Rizzo C. Age-prioritized use of antivirals during an influenza pandemic. BMC Infectious Diseases 2009; 9: 117.
3. Ciofi degli Atti ML, et al. Mitigation measures for pandemic influenza in Italy : An individual based model considering different scenarios. PLoS ONE 2008; 3: E1790.
4. Ferguson NM, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005; 437: 209-214. (Pubitemid 41294478)
5. Halloran ME, et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proceedings of the National Academy of Sciences USA 2008; 105: 4639-4645.
6. Wu JT, et al. Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Medicine 2006; 3: E361.
7. Germann TC, et al. Mitigation strategies for pandemic influenza in the United States. Proceedings of the National Academy of Sciences USA 2006; 103: 5935-5940.
8. Davey WJ, et al. Effective, robust design of community mitigation for pandemic influenza: A sytematic examination of proposed US guidance. PLoS ONE 2008; 3: E2606.
9. Longini IM Jr., et al. Containing pandemic influenza at the source. Science 2005; 309: 1083-1087. (Pubitemid 41134467)
10. Ferguson NM, et al. Strategies for mitigating an influenza pandemic. Nature 2006; 442: 448-452. (Pubitemid 44264793)
11. World Health Organization. New influenza A (H1N1) virus : global epidemiological situation, 26 June 2009. Weekly Epidemiological Record 2009; 84: 249-257 (http://www.who.int/wer/2009/wer8426/en/index.html). Accessed 13 May 2010.
12. Rizzo C, et al. Enhanced epidemiological surveillance of influenza A(H1N1)v in Italy. Eurosurveillance 2009; 14: pii=19266.
13. World Health Organization. Changes in reporting requirements for pandemic (H1N1) 2009 virus infection (http://www.who.int/csr/disease/swineflu/notes/ h1n1-surveillance-20090710/en/index.html). Accessed 13 May 2010.
14. Balcan D, et al. Seasonal transmission potential and activity peaks of the new influenza A(H1N1): A Monte Carlo likelihood analysis based on human mobility. BMC Medicine 2009; 7: 45.
15. Hayden FG, et al. Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza. Journal of the American Medical Association 1999; 282: 1240-1246.
16. World Health Organization. Guidance document: Pandemic influenza preparedness and response (http:// www.who.int/csr/disease/influenza/ pipguidance2009/en/ index.html) Accessed 13 May 2010.
17. World Health Organization. Situation updates - pandemic (H1N1) 2009 (http://www.who.int/csr/disease/ swineflu/updates/en/index.html) Accessed 13 May 2010.
18. Fraser C, et al. Pandemic potential of a strain of influenza A (H1N1): Early findings. Science 2009; 324: 1557-1561.
19. Cauchemez S, et al. Estimating the impact of school closure on influenza transmission from sentinel data. Nature 2008; 452: 750-754. (Pubitemid 351521077)
20. Xing Z, Cardona C. Preexisting immunity to pandemic (H1N1) 2009. Emerging Infectious Diseases 2009; 15 (http://www.cdc.gov/EID/content/15/11/1847.htm) Accessed 13 May 2010.
21. Reichert T, et al. Does glycosylation as a modifier of original antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza ? BMC Infectious Diseases 2010 ; 10: 5.
22. Chowell G, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. New England Journal of Medicine 2009; 361: 674-679.
23. Yang Y, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009; 326: 729-733.
24. Munayco C, et al. Epidemiological and transmissibility analysis of influenza A(H1N1)v in a southern hemisphere setting : Peru. Eurosurveillance 2009; 14: 19299.
25. Nishiura H, et al. Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Eurosurveillance 2009; 14: 19227.
26. Boelle PY, Bernillon P, Desenclos J. A preliminary estimation of the reproduction ratio for new influenza A(H1N1) from the outbreak in Mexico, March-April 2009. Eurosurveillance 2009; 14: 19205.
27. Singer AC, et al. Meeting report : Risk assessment of Tamiflu use under pandemic conditions. Environmental Health Perspectives 2008; 116: 1563-1567.
28. Cauchemez S, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. New England Journal of Medicine 2009; 361: 2619-2627.
29. Ghani AC, et al. The early transmission dynamics of H1N1pdm influenza in the United Kingdom. PLoS Currents: Influenza 2009; RRN1130.
30. Lunelli A, et al. Understanding the dynamics of seasonal influenza in Italy : An analysis of disease incidence and population susceptibility. Presented at the European Scientific Conference on Applied Infectious Disease Epidemiology, Stockholm, Sweden, 26-28 October 2009.
31. Centers for Disease Control and Prevention. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Morbidity and Mortality Weekly Report 2009; 58: 521-524.
32. Zimmer S, Burke D. Historical perspective-emergence of influenza A (H1N1) viruses. New England Journal of Medicine 2009; 361: 279-285.
33. Shaman J, Kohn M. Absolute humidity modulates influenza survival, transmission, and seasonality. Proceedings of the National Academy of Sciences USA 2009; 106: 3243-3248.
34. Shaman J, et al. Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biology 2010; 8: E1000316.
35. Miller MA, et al. The signature features of influenza pandemics - implications for policy. New England Journal of Medicine 2009; 360: 2595-2598.
36. Rizzo C, et al. Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001. Emerging Infectious Diseases 2007; 13: 694-699. (Pubitemid 46698731)